11-18358007-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005316.4(GTF2H1):c.1316C>T(p.Ala439Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,612,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A439S) has been classified as Uncertain significance.
Frequency
Consequence
NM_005316.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GTF2H1 | NM_005316.4 | c.1316C>T | p.Ala439Val | missense_variant | 12/15 | ENST00000265963.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GTF2H1 | ENST00000265963.9 | c.1316C>T | p.Ala439Val | missense_variant | 12/15 | 1 | NM_005316.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151994Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460580Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726698
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151994Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74208
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.1316C>T (p.A439V) alteration is located in exon 13 (coding exon 11) of the GTF2H1 gene. This alteration results from a C to T substitution at nucleotide position 1316, causing the alanine (A) at amino acid position 439 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at